Mechanisms of vascular smooth muscle cell ageing and calcification (renewal)

As we age, a toxic protein called prelamin A builds up inside the cells that line our blood vessels, driving them to behave like bone cells and causing the arteries to stiffen and calcify. This process—vascular calcification—is a common and dangerous consequence of ageing, yet no treatment exists to stop it. The research has already shown that when prelamin A accumulates in the vessel-wall cells of mice, the animals develop enlarged aortas, hardened arteries, high blood pressure, and die prematurely. At the molecular level, the team has mapped a precise sequence of events: DNA damage, epigenetic changes, premature cell ageing, and the activation of bone-forming genes. Now, the researchers will test whether drugs or genetic tweaks can interrupt this cascade. Using human tissue samples alongside animal and cell models, they aim to identify new targets for therapy. If successful, this work could lead to the first treatments for vascular calcification—potentially preventing heart attacks, strokes, and aortic ruptures in older adults. This is fundamental science with a clear translational goal: turning a detailed molecular timeline into a clinical intervention.